StreetAlpha.app
Home › Stocks › COCH

Envoy Medical, Inc. (COCH)

$6.70
▲ +0.00%
LAST CLOSE · NOV 20

Envoy Medical is a White Bear Lake, Minnesota company developing a fully implanted cochlear implant for people with hearing loss. It last closed at $6.70 on Nov 20, up 0.00% on the day. The next earnings report for COCH is expected around Fri, Mar 26, 2027, after the close. For the quarter ended Sep 2026, COCH reported EPS of -$0.50 on revenue of $66,000, with revenue up 57.1% from a year ago. Over its last 8 reports the stock moved an average of 3.0% the session after earnings. Over the last 12 months COCH insiders bought $8.2M of stock on the open market and sold $0, according to SEC Form 4 filings.

AI Auto Pilots
Is COCH in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold COCH.

Key Stats

Last 12 months
Results
Revenue
$231K
+11.1% vs a year ago
Net income
−$20.9M
−9026.4% margin
Free cash flow
−$22.4M
−9713.0% margin
Gross margin
−352.8%
−$815K gross profit
Valuation
Market cap
$51.9M
7.7M shares
P/E
–
Price to sales
224.6
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$14.6M
At Sep 30
Shareholder equity
−$1.5M
Shares outstanding
7.7M
At Nov 5
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2022: $237K$237KFY2022FY2023: $316K$316KFY2023FY2024: $225K$225KFY2024FY2025: $241K$241KFY2025

From COCH's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Next report
Mar 26
Estimated date · After the close
Reported EPS
-$0.50
Quarter ended Sep 2026
Year ago EPS
-$3.55
Same quarter last year
Revenue
$66,000
+57.1% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.40Dec '24Mar 2025: -$0.29Mar '25Jun 2025: -$0.32Jun '25Sep 2025: -$3.55Sep '25Dec 2025: $8.49Dec '25Mar 2026: -$0.08Mar '26Jun 2026: -$0.07Jun '26Sep 2026: -$0.50Sep '26Latest -$0.50
Revenue by quarter
Dec 2024: $42,000Dec '24Mar 2025: $46,000Mar '25Jun 2025: $78,000Jun '25Sep 2025: $42,000Sep '25Dec 2025: $75,000Dec '25Mar 2026: $39,000Mar '26Jun 2026: $51,000Jun '26Sep 2026: $66,000Sep '26Latest $66,000
How COCH moved after its last 8 reports
Average move the session after a report ±3.0%
Nov 5, 2026Time not announced−0.3%
Aug 10, 2026After the close+9.2%
May 11, 2026Time not announced−0.2%
Mar 27, 2026After the close−1.5%
Nov 10, 2025Time not announced−0.3%
Jul 31, 2025Time not announced−6.2%
May 1, 2025After the close−2.2%
Mar 31, 2025Time not announced−4.4%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on COCHStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on COCH
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on COCH

Technical Analysis

COCH · as of the Nov 20 close · updated each morning
Moving sideways

The stock is 1% below its 20 day and 1% below its 50 day average. It is 3% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 48). The nearest support is the Pivot at $6.68, and the nearest resistance the swing high (Oct 9) at $6.71.

Short trendNeutral
Long trendNeutral
MomentumFading
StretchNormal
VolatilityNormal, 6.7%/day
Key levels
$9.5452 week high+42.4%
$6.95100 day average+3.7%
$6.90200 day average+3.0%
$6.87Pivot R1+2.5%
$6.7920 day average+1.3%
$6.7650 day average+0.9%
$6.71Swing high (Oct 9)+0.1%
$6.70Last close
$6.68Pivot−0.3%
$6.67Swing low (May 27)−0.4%
$6.52Pivot S1−2.7%
$3.6252 week low−46.0%
Indicators
RSI (14)47.81Middle of its rangeNeutral
MACD0.02Below its signal lineBearish
Stochastic27.0Middle of its rangeNeutral
ADX (14)27.8Trending down
Williams %R-79.2Oversold below −80, overbought above −20Neutral
CCI (20)-33.4Oversold below −100, overbought above 100Neutral
Rate of change−6.3%Change over 10 sessionsBearish
ATR (14)$0.45Typical daily range, 6.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for COCH

What happened before

See how COCH did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow COCH usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How COCH has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for COCHHow many large options trades hit COCH, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

COCH Insider Trading

All filings →
Insider trading · 12 months
Insiders are net buyers
Bought$8.2M6 buys · 6 insiders
Sold$00 sales · 0 insiders
Cluster buy: 6 insiders bought $8.2M between Feb 12 and Feb 12.
2026-02 bought $8.2MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Feb 12Brent T. LucasCEOBuy62,500$0.40$25K
Feb 12Charles BrynelsenDirectorBuy1,000,000$0.40$400K
Feb 12Susan KantorDirectorBuy96,150$0.40$38K
Feb 12Robert PotashnickInterim CFOBuy212,500$0.40$85K
Feb 12Mona Chetan PatelDirectorBuy312,500$0.40$125K
Feb 12Glen A Taylor10% ownerBuy18,750,000$0.40$7.5M
Every insider buy and sale for COCH over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See COCH insider trades →

From SEC Form 4 filings by COCH's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether COCH is in one of them and how their past COCH trades turned out.

COCH in the AI portfolios
Loading…

COCH News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered COCH in an article yet. Here's the latest on the wider market.

COCH in the news

About Envoy Medical

Envoy Medical is a hearing health company based in White Bear Lake, Minnesota. It is developing the Acclaim CI, a fully implanted cochlear implant that uses a sensor placed in the middle ear to pick up sound, so no external parts need to be worn. The device is still investigational and has not yet received FDA approval for sale. Its intended customers are adults with hearing loss and the surgeons and clinicians who treat them.

Headquarters
White Bear Lake, MN